Clinical Trials Logo

Filter by:
NCT ID: NCT05623345 Active, not recruiting - Psoriatic Arthritis Clinical Trials

Psoriatic Arthritis Study of Izokibep

Start date: November 21, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

Izokibep is a potent and selective inhibitor of interleukin (IL)-17A that is being developed for treatment of psoriatic arthritis (PsA). This study will evaluate the efficacy of izokibep in subjects with PsA.

NCT ID: NCT05623189 Active, not recruiting - Type 2 Diabetes Clinical Trials

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

CENTRICITY
Start date: December 27, 2022
Phase: Phase 2
Study type: Interventional

A phase 2b, multicenter, randomized, double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes mellitus or pre-diabetes.

NCT ID: NCT05622903 Active, not recruiting - Clinical trials for Health Care Utilization

Effect of Cash Benefits on Health Care Utilization

Start date: July 27, 2020
Phase: N/A
Study type: Interventional

Using data from the Chelsea Eats program, we propose to study a randomized controlled trial in which the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months during the first two years of the COVID-19 pandemic. We will analyze the impact of the cash benefit on health care utilization and health.

NCT ID: NCT05622045 Active, not recruiting - Obesity Clinical Trials

Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)

StoryLCSS
Start date: February 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about the personality attributes and values of people living with obesity that are part of the Latino community, and how these personality attributes and values can help to predict success during a weight loss program. The main questions it aims to answer are: - What are the personality attributes and values of people living with obesity that sign up to the LCSS-Latino Crossover Semaglutide Study trial? - Can behavioral artificial intelligence (a computer formula) predict which patients will complete the LCSS-Latino Crossover Semaglutide Study trial? - How do behavioral artificial Intelligence predictions (a computer formula) compare to clinician predictions of patient success? - Can behavioral artificial intelligence (a computer formula) predict patient weight loss, calorie consumption and physical activity levels during the LCSS-Latino Crossover Semaglutide Study trial? Participants will be recorded in English and Spanish while responding to a question regarding participation in a weight loss study.

NCT ID: NCT05620979 Active, not recruiting - Cancer Clinical Trials

Financial Navigation Study Among Young Adult Blood Cancer Survivors

Start date: February 14, 2022
Phase: N/A
Study type: Interventional

Young adult cancer survivors (18-39y) are at increased risk of financial distress. This study seeks to better understand the financial challenges experienced by these individuals via quantitative serial assessments, study-based financial navigator encounters and an end of study qualitative interview.

NCT ID: NCT05620225 Active, not recruiting - Neuropathic Pain Clinical Trials

Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management

Start date: December 15, 2022
Phase: N/A
Study type: Interventional

Compare Axon Therapy plus conventional medical management (CMM) to Sham plus CMM in reducing neuropathic pain in patients with painful diabetic neuropathy (PDM).

NCT ID: NCT05619692 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Start date: December 27, 2022
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Alzheimer's Disease.

NCT ID: NCT05619146 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Arm and Leg Cycling for Accelerated Recovery From SCI

Start date: January 23, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the ability of simultaneous motorized upper and lower extremity cycling training to regulate spinal movement patterns in order to potentially restore functional abilities (i.e., walking) in individuals with an incomplete spinal cord injury. The researchers hypothesize there will be improved walking function following motorized cycling.

NCT ID: NCT05618678 Active, not recruiting - Dementia Clinical Trials

Pilot Testing Decision Making in Aging and Dementia for Autonomy Program in Nursing Homes

DIGNITY
Start date: January 24, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to adapt, pilot test, and evaluate the feasibility, acceptability, and preliminary effectiveness of DIGNITY (Decision-making In aGing and demeNtIa for auTonomY) for Preference-Based Care in Nursing Homes as a new evidence-based intervention to support nursing home staff to safely honor care and activity preferences of residents' living with dementia in rural, typically under resourced nursing home communities.

NCT ID: NCT05618613 Active, not recruiting - Breast Cancer Clinical Trials

Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer

ELONA
Start date: December 2, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, Phase 1b-2 study of elacestrant in combination with onapristone in patients with advanced/metastatic ER+/PgR+/HER2- breast cancer.